Citadel Advisors’s HUTCHMED HCM Stock Holding History
Bought
Maintained
Sold
Other funds holding HCM
AG
MGP
XC
Citadel Advisors's HCM Position: Q2 2026 in Review
Citadel Advisors increased its HUTCHMED (HCM) stake by 25% in Q2 2026, buying an estimated $95.4K and bringing the position to 38,061 shares worth $410K. The position accounts for ﹤0.01% of the portfolio, ranked #10364.
Citadel Advisors first reported a position in HCM in Q1 2018 and has held it in 27 quarters since. The position peaked at $3.21M in Q4 2022. 56 funds tracked by Wall St. Rank hold HCM as of Q2 2026.
- Citadel Advisors held 38,061 shares of HUTCHMED worth $410K as of Q2 2026.
- Citadel Advisors bought 7,547 HUTCHMED shares in Q2 2026, an estimated $95.4K.
- HUTCHMED made up ﹤0.01% of Citadel Advisors's portfolio in Q2 2026, its #10364 holding.
- Citadel Advisors first reported a position in HUTCHMED in Q1 2018 and has held it in 27 quarters since.
- Citadel Advisors's HUTCHMED position peaked at $3.21M in Q4 2022.
- 56 funds tracked by Wall St. Rank held HUTCHMED as of Q2 2026.
Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.